Ayala Pharmaceuticals (NASDAQ:ADXS) Research Coverage Started at StockNews.com
StockNews.com began coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a research report sent to investors on Thursday. The brokerage issued a sell rating on the stock. Ayala Pharmaceuticals Price Performance Shares of ADXS opened at $0.03 on Thursday. Ayala Pharmaceuticals has a twelve month low of $0.00 and a twelve month […]
More Stories
CNB Bank Cuts Position in Bristol-Myers Squibb (NYSE:BMY)
CNB Bank reduced its position in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 6.5% in the 3rd quarter,...
Baron Financial Group LLC Sells 1,170 Shares of iShares Core S&P Mid-Cap ETF (NYSEARCA:IJH)
Baron Financial Group LLC reduced its stake in iShares Core S&P Mid-Cap ETF (NYSEARCA:IJH – Free Report) by 4.2% in...
Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Acquired by Alta Wealth Advisors LLC
Alta Wealth Advisors LLC boosted its position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 3.8%...
Proathlete Wealth Management LLC Buys New Shares in The Home Depot, Inc. (NYSE:HD)
Proathlete Wealth Management LLC purchased a new position in shares of The Home Depot, Inc. (NYSE:HD – Free Report) during...
Chicago Capital LLC Has $2.39 Million Stock Position in Walmart Inc. (NYSE:WMT)
Chicago Capital LLC lessened its stake in Walmart Inc. (NYSE:WMT – Free Report) by 0.5% in the 3rd quarter, according...
AA Financial Advisors LLC Raises Stock Holdings in Salesforce, Inc. (NYSE:CRM)
AA Financial Advisors LLC raised its position in shares of Salesforce, Inc. (NYSE:CRM – Free Report) by 8.0% in the...